Pharmaceuticals, Biotechnology and Life Sciences
Clinical-development joint venture commended for staff growth and retention WILMINGTON, N.C. & TOKYO–(BUSINESS WIRE)–PPD-SNBL, the joint venture of Pharmaceutical Product…
IASO Biotherapeutics unveils an innovative new CAR-T therapy for the treatment of relapse/refractory multiple myeloma and the retreatment of previously…
DUBLIN–(BUSINESS WIRE)–The “HPLC Systems and Accessories: Global Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. This…
Liquid biopsy assay with recent Breakthrough Device Designation from FDA is being used to screen patients with prostate cancer for…
MONTREAL–(BUSINESS WIRE)–#HR–BIOQuébec and BioTalent Canada have announced a collaboration agreement to facilitate access to human resources services specific to life…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to…
It is estimated that there were approximately 92.2
million prevalent cases of uterine fibroids worldwide in females aged
15 years and over, and forecasts that number to increase to 102.7
million prevalent cases by 2026.
DUBLIN–(BUSINESS WIRE)–The “Global Anti-tuberculosis Therapeutics Market Growth, Trends and Forecasts Through 2019-2024” report has been added to ResearchAndMarkets.com’s offering. The…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Irritable Bowel Syndrome (IBS)” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Duchenne Muscular Dystrophy (DMD)” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers…